GREAT POINT PARTNERS LLC Quant / Systematic

CIK: 0001281446 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $349,225 (100.0% shares, 0.0% debt)

Holdings (39)

ADAMAS PHARMACEUTICALS INC 9.1%
Value ($000) $31,932 Shares 2,109,099 Est. Cost $18.75 Unrealized
VNDA VANDA PHARMACEUTICALS INC 8.7%
Value ($000) $30,277 Shares 2,705,758 Est. Cost $10.50 Unrealized -7.7%
SYNERGY PHARMACEUTICALS DEL 8.3%
Value ($000) $28,842 Shares 7,590,000 Est. Cost $4.49 Unrealized
EXEL EXELIXIS INC 7.2%
Value ($000) $24,992 Shares 3,200,000 Est. Cost $4.88 Unrealized +18.1%
DERMIRA INC 6.7%
Value ($000) $23,400 Shares 800,000 Est. Cost $29.25 Unrealized
BLUEBIRD BIO INC 6.2%
Value ($000) $21,645 Shares 500,000 Est. Cost $42.67 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 6.1%
Value ($000) $21,362 Shares 470,000 Est. Cost $41.64 Unrealized +10.6%
EGRX EAGLE PHARMACEUTICALS INC 6.1%
Value ($000) $21,268 Shares 548,290 Est. Cost $41.64 Unrealized 0.0%
ZOGENIX INC 5.6%
Value ($000) $19,650 Shares 2,440,959 Est. Cost $11.56 Unrealized
IGNYTA INC 5.0%
Value ($000) $17,554 Shares 3,238,703 Est. Cost $5.54 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 3.4%
Value ($000) $11,863 Shares 538,024 Est. Cost $26.18 Unrealized 0.0%
SAGE THERAPEUTICS INC 2.8%
Value ($000) $9,943 Shares 330,000 Est. Cost $30.13 Unrealized
TETRAPHASE PHARMACEUTICALS I 2.8%
Value ($000) $9,888 Shares 2,299,529 Est. Cost $6.71 Unrealized
CONNECTURE INC 2.7%
Value ($000) $9,328 Shares 4,127,232 Est. Cost $9.01 Unrealized
XNCR XENCOR INC 2.4%
Value ($000) $8,546 Shares 450,000 Est. Cost $11.83 Unrealized +15.9%
AUPH AURINIA PHARMACEUTICALS INC 2.1%
Value ($000) $7,192 Shares 2,457,144 Est. Cost $3.52 Unrealized -22.5%
ALCOBRA LTD 1.8%
Value ($000) $6,351 Shares 1,414,573 Est. Cost $5.99 Unrealized
RAPTOR PHARMACEUTICAL CORP 1.5%
Value ($000) $5,254 Shares 978,350 Est. Cost $5.98 Unrealized
SRPT SAREPTA THERAPEUTICS INC 1.3%
Value ($000) $4,556 Shares 238,900 Est. Cost Unrealized
SUNESIS PHARMACEUTICALS INC 1.3%
Value ($000) $4,477 Shares 8,173,937 Est. Cost $1.47 Unrealized
BOVIE MEDICAL CORP 1.3%
Value ($000) $4,395 Shares 2,680,000 Est. Cost $2.72 Unrealized
ARADIGM CORP 1.3%
Value ($000) $4,383 Shares 1,002,962 Est. Cost $8.85 Unrealized
INTRA CELLULAR THERAPIES INC 1.1%
Value ($000) $3,882 Shares 100,000 Est. Cost $38.82 Unrealized
OCERA THERAPEUTICS INC 1.1%
Value ($000) $3,731 Shares 1,963,777 Est. Cost $6.20 Unrealized
SERES THERAPEUTICS INC 1.0%
Value ($000) $3,486 Shares 120,000 Est. Cost Unrealized
TENAX THERAPEUTICS INC 0.8%
Value ($000) $2,838 Shares 1,108,593 Est. Cost $3.93 Unrealized
FOAMIX PHARMACEUTICALS LTD 0.5%
Value ($000) $1,745 Shares 274,756 Est. Cost $6.35 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.5%
Value ($000) $1,738 Shares 550,116 Est. Cost $3.16 Unrealized
ASND ASCENDIS PHARMA A S 0.3%
Value ($000) $1,015 Shares 76,511 Est. Cost $13.27 Unrealized
CALADRIUS BIOSCIENCES INC 0.3%
Value ($000) $900 Shares 1,525,244 Est. Cost $1.87 Unrealized
DIPEXIUM PHARMACEUTICALS INC 0.2%
Value ($000) $871 Shares 87,914 Est. Cost $9.91 Unrealized
VCEL VERICEL CORP 0.2%
Value ($000) $570 Shares 253,502 Est. Cost $2.85 Unrealized +1.3%
PARATEK PHARMACEUTICALS INC 0.1%
Value ($000) $407 Shares 29,266 Est. Cost $25.19 Unrealized
AXOVANT SCIENCES LTD 0.1%
Value ($000) $321 Shares 25,000 Est. Cost $12.84 Unrealized
REVANCE THERAPEUTICS INC 0.1%
Value ($000) $295 Shares 21,665 Est. Cost $13.62 Unrealized
STREAMLINE HEALTH SOLUTIONS 0.1%
Value ($000) $182 Shares 151,611 Est. Cost $6.45 Unrealized
RIGEL PHARMACEUTICALS INC 0.0%
Value ($000) $112 Shares 50,000 Est. Cost $2.08 Unrealized
ARDX ARDELYX INC 0.0%
Value ($000) $30 Shares 3,444 Est. Cost $8.17 Unrealized 0.0%
AMARIN CORP PLC 0.0%
Value ($000) $4 Shares 2,000 Est. Cost $2.00 Unrealized